S1 EP3: Potential Treatment Options: A Focus on Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction

We are joined by Professor Javed Butler, Chair of the Department of Medicine at University of Mississippi Medical Center in Jackson, Mississippi, United States. His main area of research is heart failure, a topic on which he’s authored more than 650 peer-reviewed publications.In the last episode, we discussed some promising results in the EMPEROR-Preserved trials where empagliflozin was shown to benefit patients with preserved ejection fraction. In this podcast, we will discuss the benefits o...